HIV treatment as prevention among men who have sex with men in the UK: Is transmission controlled by universal access to HIV treatment and care?

HIV Medicine

Volumn 14, Issue 9, 2013, Pages 563-570

  Brown, Alison E ^a   Gill, O N ^a   Delpech, V C ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

HIV; Men who have sex with men; Transmission; Treatment as prevention

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CHEMOPROPHYLAXIS; DRUG UTILIZATION; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PRIORITY JOURNAL; UNITED KINGDOM; VIRUS LOAD;

HIV; MEN WHO HAVE SEX WITH MEN; TRANSMISSION; TREATMENT AS PREVENTION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, INFECTIOUS; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PREVENTIVE MEDICINE; RISK-TAKING; SAFE SEX; VIRAL LOAD;

EID: 84883448698     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12066     Document Type: Article

References (35)

1. Karim SSA, Karim QA. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet 2011; 378: e23-e25.
2. Cohen J. Breakthrough of the year. Science 2011; 334: 1628.
3. Cohen MS, Chen YQ, McCauley M etal. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
4. Babiker AG, Emery S, Fätkenheuer G etal. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clin Trials 2013; 10: S5-S36.
5. Montaner JSG. Treatment as prevention - a double hat-trick. Lancet 2011; 378: 208-209.
6. Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in Care of Adults and Adolescents living with HIV in the 13 US areas. 2012. J Acquir Immune Defic Syndr 2012; 60: 77-82.
7. Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of Engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52: 793-800.
8. Das M, Chu PL, Santos GM, Sheer S, Vittinghoff E, McFarland W, Colfax GN. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5E: E11068.
9. Montaner JSG, Limda VD, Barrios J etal. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376: 532-539.
10. Health Protection Agency. Sexually transmitted infections in men who have sex with men in the UK: 2011 Report. November 2011. Available at www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131685989 (accessed 17 July 2013).
11. Health Protection Agency. HIV in the United Kingdom: 2011 Report. London: Health Protection Services, Colindale. November 2011. Available at www.hpa.org.uk/Publications/InfectiousDiseases/HIVAndSTIs/1211HIVintheUK2012/ (accessed 17 July 2013).
12. Rice BD, Delpech VC, Chadborn TR, Elford J. Loss to follow up among adults attending Human Immunodeficiency virus services in England, Wales and Northern Ireland. Sex Transm Dis 2011; 38: 685-690.
13. Brown AE, Kall MM, Smith RD, Hunter AS, Delpech VC. Auditing national HIV guidelines and policies: the United Kingdom CD4 surveillance scheme. Open Aids J 2012; 6: 149-155.
14. United States treatment guidelines 2008. Available at http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL001561.pdf (accessed 17 July 2013).
15. Gazzard BG, British HIV. Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 2008; 9: 563-608.
16. United States treatment guidelines 2009. Available at http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL001226.pdf (accessed 17 July 2013).
17. British HIV Association guidelines under consultation. Available at www.bhiva.org/documents/Guidelines/Treatment%20Guidelines/2012/formatted__ART_guidelines_04022012_v3_IW.pdf (accessed 17 July 2013).
18. Available at www.who.int/hiv/pub/guidelines/arv2013/short_summary/en/index.html (accessed 17 July 2013).
19. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta analysis. AIDS 2009; 23: 1397-1404.
20. Smith RD, Delpech VC, Brown AE, Rice BD. HIV transmission and high rates of late diagnoses among adults aged 50 years and over. AIDS 2010; 24: 2109-2115.
21. Rice BD, Payne LJ, Sinka K, Patel B, Evans BG, Delpech VC. The changing epidemiology of prevalent diagnosed HIV infections in England, Wales, and Northern Ireland, 1997 to 2003. Sex Transm Infect 2005; 81: 223-229.
22. Presanis AM, Gill ON, Chadborn TR etal. Insights into the rise in HIV infections, 2001 to 2008: a Bayesian synthesis of prevalence evidence. AIDS 2010; 24: 2849-2858.
23. Goubar A, Ades AE, De Angelis D etal. Estimates of human immuno-deficiency virus prevalence and proportion diagnosed based on bayesian multi-parameter synthesis of surveillance data. J R Stat Soc Ser A Stat Soc 2008; 171: 541-580.
24. MPES method on the HPA website. Available at www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1201767906472 (accessed 17 July 2013).
25. Catchpole MA, McGarrigle CA, Rogers PA, Jordan LF, Mercey D, Gill ON. Serosurveillance of prevalence of undiagnosed HIV-1 infection in homosexual men with acute sexually transmitted infection. BMJ 2000; 321: 1319-1320.
26. Unlinked Anonymous survey of STI clinic attendees on the HPA website. Available at www.hpa.org.uk/webc/%20HPAwebFile/HPAweb_C/1287145034423 (accessed 17 July 2013).
27. Gorbach PM, Weiss RE, Jeffries R, Javanbakht M, Drumright LN, Daar ES, Little SJ. Behaviors of recently HIV-infected men who have sex with men in the year post-diagnosis: effects of drug use and partner types. J Acquir Immune Defic Syndr 2011; 56: 176-182.
28. Pilcher CD, Joaki G, Hoffman IF etal. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007; 21: 1723-1730.
29. Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, Nardone A. Who would use PrEP? Factors associated with intention to use among MSM in London:a community survey. Sex Transm Infect 2013; 89: 207-211.
30. Birrell PJ, Gill ON, Delpech VC, Brown AE, Desai S etal. Trends in HIV incidence among men who have sex with men in England and Wales in the era of increased HIV testing and treatment: a nationwide population study 2001 to 2010. Lancet Infect Dis 2013; 13: 313-318.
31. Phillips AN, Cambiano V, Nakagawa F, Brown AE, Lampe F etal. Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS One 2013; 8: e55312.
32. Meussig KA, Smith MK, Powers KA etal. Does ART prevent HIV transmission among MSM? AIDS 2012; 26: 2267-2274.
33. Benn P, Fisher M, Kulasegaram R, BASHH and the PEPSE Guidelines Writing Group Clinical Effectiveness Group. UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS 2011; 22: 695-708.
34. Hilary Curtis. 2012-13 audit of patients with diagnosed HIV infection apparently not in care. 19th Annual Conference of the British HIV Association. Manchester Central Convention Complex, April 2013. Available at http://bhiva.org/NationalAuditReports.aspx.
35. Dodds J, Johnson AM, Parry JV, Mercey D. A tale of three cities: persisting high HIV prevalence, risk behaviour and undiagnosed infection in community samples of men who have sex with men. AIDS 2007; 83: 392-396.